CRH Medical Corp (CVE:CRM)’s share price hit a new 52-week low during trading on Friday . The company traded as low as C$2.67 and last traded at C$2.68, with a volume of shares.
Separately, CIBC lowered shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a report on Monday, July 17th.
ILLEGAL ACTIVITY NOTICE: “CRH Medical Corp (CRM) Sets New 52-Week Low at $2.67” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/09/08/crh-medical-corp-crm-sets-new-52-week-low-at-2-67.html.
CRH Medical Corp Company Profile
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company’s lead product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.